Search research articles
Contact Us
Filters
Showing results (51-60 of 61) with videos related to
Page
of 7
Sort By:
Journal of Arrhythmia
|
January 16, 2025
Two-year clinical outcomes of Taiwanese and other Asian ethnicities with atrial fibrillation treated with edoxaban in the ETNA-AF Asia registry
Chun-Chieh Wang, Cheng-I Cheng, Kwo-Chang Ueng, et al.
JACC. Cardiovascular Interventions
|
February 11, 2026
Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AF
George D Dangas, Martin Unverdorben, Christian Hengstenberg, et al.
Research Square
|
June 12, 2025
Host-Derived Geranylgeraniol Shields Intraerythrocytic Stages of Malaria Parasites from Fosmidomycin
Ignasi Verdaguer, Cathy Chen, Maurício Mazzine Filho, et al.
Clinical Cardiology
|
October 26, 2019
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design
Raffaele De Caterina, Giancarlo Agnelli, Petra Laeis, et al.
JACC. Advances
|
June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR
Roxana Mehran, Alessandro Spirito, James Jin, et al.
Frontiers in Pharmacology
|
February 9, 2026
Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study
Xueyuan Guo, Juan Du, Yuehui Yin, et al.
Scientific Reports
|
February 2, 2024
Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry
Xueyuan Guo, Juan Du, Yang Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 14, 2022
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients - A Subanalysis of the ENVISAGE-TAVI AF Trial
Yusuke Watanabe, Kentaro Hayashida, Masanori Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 2, 2003
A strabismus susceptibility locus on chromosome 7p
Vaishali Parikh, Yin Yao Shugart, Kimberly F Doheny, et al.
Journal of the American Heart Association
|
February 15, 2018
Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank
Rachel D Torok, Jennifer S Li, Prince J Kannankeril, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 61) with videos related to
Sort By:
Page
of 7
Journal of Arrhythmia
|
January 16, 2025
Two-year clinical outcomes of Taiwanese and other Asian ethnicities with atrial fibrillation treated with edoxaban in the ETNA-AF Asia registry
Chun-Chieh Wang, Cheng-I Cheng, Kwo-Chang Ueng, et al.
JACC. Cardiovascular Interventions
|
February 11, 2026
Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR: The HARHP Score Results From ENVISAGE-TAVI AF
George D Dangas, Martin Unverdorben, Christian Hengstenberg, et al.
Research Square
|
June 12, 2025
Host-Derived Geranylgeraniol Shields Intraerythrocytic Stages of Malaria Parasites from Fosmidomycin
Ignasi Verdaguer, Cathy Chen, Maurício Mazzine Filho, et al.
Clinical Cardiology
|
October 26, 2019
The global Edoxaban Treatment in routine cliNical prActice (ETNA) noninterventional study program: rationale and design
Raffaele De Caterina, Giancarlo Agnelli, Petra Laeis, et al.
JACC. Advances
|
June 28, 2024
Sex Differences Among Patients Receiving Edoxaban vs Vitamin K Antagonist for Atrial Fibrillation After TAVR
Roxana Mehran, Alessandro Spirito, James Jin, et al.
Frontiers in Pharmacology
|
February 9, 2026
Edoxaban for stroke prevention in Chinese patients with atrial fibrillation: 1-year follow-up of the ETNA-AF-China study
Xueyuan Guo, Juan Du, Yuehui Yin, et al.
Scientific Reports
|
February 2, 2024
Edoxaban for stroke prevention in atrial fibrillation and factors associated with dosing: patient characteristics from the prospective observational ETNA-AF-China registry
Xueyuan Guo, Juan Du, Yang Yang, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society
|
August 14, 2022
Edoxaban vs. Vitamin K Antagonist for Atrial Fibrillation After Transcatheter Aortic Valve Replacement in Japanese Patients - A Subanalysis of the ENVISAGE-TAVI AF Trial
Yusuke Watanabe, Kentaro Hayashida, Masanori Yamamoto, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 2, 2003
A strabismus susceptibility locus on chromosome 7p
Vaishali Parikh, Yin Yao Shugart, Kimberly F Doheny, et al.
Journal of the American Heart Association
|
February 15, 2018
Recommendations to Enhance Pediatric Cardiovascular Drug Development: Report of a Multi-Stakeholder Think Tank
Rachel D Torok, Jennifer S Li, Prince J Kannankeril, et al.
Page
of 7